<b>Gapping Up<br/>In reaction to strong earnings/guidance:</b><br/>IRET +6.1%, KMG +6%, RCMT +5.1% (Guidance), URBN +0.9%, (Sales Update).<br/><b>M&A news:</b><br/>RPRX +40.5% (to be acquired by Allergan plc (AGN) for $0.67/share in cash),<br/>ALV +1.2% (concludes strategic review and prepares for spin-off of its electronics segment). <br/><b>Other news:</b><br/>PTI +44.7% (announced positive study results across all three of the company's CF pipeline programs),<br/>APTO +6.1% (presents preclinical demonstrating that CG'806, a highly potent pan-FLT3/pan-BTK inhibitor, exerts a profound anti-leukemia effect in human and murine leukemia cell lines harboring FLT-3 ITD mutations),<br/>ATNM +5.8% (ticking higher after highlighting data at ASH showing CD33 expression in significant number of multiple myeloma patients supporting the rationale for Actimab-M),<br/>PGLC +3.3% (announces bought deal of $6.8 million and concurrently announces private placement ),<br/>OSTK +3.1% (continued momentum),<br/>BA +1.2% (Boeing raises quarterly dividend 20% to $1.71/share and replaces the existing share repurchase program with a new $18 billion authorization ),<br/>AGIO +0.9% (presents new efficacy and safety data from ongoing Phase 1 study evaluating oral ivosidenib (AG-120) in patients with relapsed or refractory acute myeloid leukemia and an isocitrate dehydrogenase-1 mutation),<br/>YTEN +0.9% (after closing up 180% higher on Monday),<br/>EGLE +0.9% (completes $265 million refinancing; extended the maturities of the outstanding debt of its subsidiaries through 2022),<br/>GSK +0.9% (reports new data for priority BCMA asset from its emerging Oncology pipeline; 60% response rate),<br/>SND +0.8% (files for $200 mln mixed securities shelf offering and 19,078,415 share offering by holders). <br/><b>Analyst comments:</b><br/>COTY +3.9% (upgraded to Buy from Neutral at Citigroup),<br/>ATVI +2.4% (upgraded to Buy from Neutral at Goldman),<br/>NOC +1.7% (upgraded to Overweight from Neutral at JP Morgan),<br/>ZAYO +1.7% (upgraded to Overweight from Equal-Weight at Morgan Stanley),<br/>TER +1.5% (upgraded to Buy from Neutral at Goldman),<br/>FCX +0.9% (upgraded to Equal-Weight from Underweight at Morgan Stanley),<br/>ABT +0.7% (upgraded to Outperform from Market Perform at BMO Capital Markets),<br/>CAG +0.7% (upgraded to Neutral from Sell at UBS).<br/><b>Gapping Down<br/>In reaction to disappointing earnings/guidance:</b><br/>PPHM -18.7%, CASY -4.3%.<br/><b>Other news:</b><br/>MARA -13.7% (agreed to sell 1 mln shares of common stock for gross proceeds of approximately $5.0 mln in registered direct offering),<br/>ACER -8.2% (to offer and sell shares of its common stock),<br/>NCS -6.6% (Prices 7.15 mln common stock offering by investment funds associated with Clayton Dubilier & Rice at $19.55/share),<br/>OAS -3.6% (Buys 20,300 acres in the Delaware Basin for ~$946 mln, expects to divest non-core Williston Basin acreage up to $500 mln in 2018; Co separately announced that it has commenced an underwritten public offering of 32 mln shares of common stock),<br/>NCS -2.9% (announces secondary offering of 7,150,000 shares of common stock by investment funds associated with Clayton Dubilier & Rice),<br/>EIX -2.7% (Southern California Edison confirms multiple wind-driven wildfires moving through Southern California are affecting customers and electric service in Southern California Edison's service territory),<br/>BPMC -2.6% (commences underwritten public offering of $275 mln in shares of its common stock),<br/>UTL -2.1% (to offer 600k shares of common stock pursuant to an effective shelf registration statement),<br/>IRM -1.8% (to acquire the US operations of IO Data Centers for $1.315 billion plus up to $60 million based on future performance; commenced an underwritten public offering of 14,500,000 shares of its common stock),<br/>ARGX -1.8% (files for $150 mln ADS offering),<br/>BLUE -1.7% (commenced an underwritten public offering of $600 million of its common stock),<br/>H -1.7% ( indicated lower on block trade pricing).<br/><b>Analyst comments:<br/></b>CASY -5.2% (downgraded to Mkt Perform from Outperform at Raymond James),<br/>EVTC -2.6% (downgraded to Underweight from Neutral at JP Morgan),<br/>MGI -2.2% (downgraded to Underweight from Neutral at JP Morgan),<br/>PEGI -1.9% (downgraded to Equal-Weight from Overweight at Morgan Stanley),<br/>BRG -1.6% (downgraded to Neutral from Buy at Janney).<br/><br/>Briefing.com